D. Boral Capital Upgrades Citius Pharmaceuticals to Buy
D. Boral Capital has upgraded Citius Pharmaceuticals (CTXR) stock to Buy from Hold, citing Lymphir's imminent commercialization with a $9 price target.
Topic
Stock Upgrade
A collection of 55 issues
Raymond James Upgrades American Airlines to Outperform
Raymond James upgrades American Airlines (AAL) to Outperform, setting a $24 price target. Improved revenue outlook boosts confidence in AAL stock.
Citius Pharmaceuticals Upgraded to Buy with $9 Target
Citius Pharmaceuticals (CTXR) gets a Buy upgrade from D. Boral Capital with a $9 price target, driven by the anticipated commercialization of Lymphir.
Raymond James Upgrades American Airlines to Outperform
Raymond James has upgraded American Airlines (AAL) to Outperform with a $24 price target, citing an improved revenue outlook for the airline.
Wedbush Raises Apple Price Target, Boosting Growth Confidence
Wedbush has increased Apple's price target, reflecting strong confidence in the tech giant's continued growth. Discover the impact on Apple's stock value.